These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 20072950)

  • 1. Expression of proteins associated with therapy resistance in rhabdomyosarcoma and neuroblastoma tumour cells.
    Pituch-Noworolska A; Zaremba M; Wieczorek A
    Pol J Pathol; 2009; 60(4):168-73. PubMed ID: 20072950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of the breast cancer resistance protein (BCRP) in relapsed or refractory acute myeloid leukemia (AML).
    van den Heuvel-Eibrink MM; Wiemer EA; Prins A; Meijerink JP; Vossebeld PJ; van der Holt B; Pieters R; Sonneveld P
    Leukemia; 2002 May; 16(5):833-9. PubMed ID: 11986944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
    Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
    Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of multidrug resistance-related proteins in childhood acute lymphoblastic leukaemia.
    Swerts K; De Moerloose B; Dhooge C; Laureys G; Benoit Y; Philippé J
    Eur J Cancer; 2006 Feb; 42(3):295-309. PubMed ID: 16324833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of multidrug resistance proteins P-glycoprotein, multidrug resistance protein 1, breast cancer resistance protein and lung resistance related protein in locally advanced bladder cancer treated with neoadjuvant chemotherapy: biological and clinical implications.
    Diestra JE; Condom E; Del Muro XG; Scheffer GL; Pérez J; Zurita AJ; Muñoz-Seguí J; Vigués F; Scheper RJ; Capellá G; Germà-Lluch JR; Izquierdo MA
    J Urol; 2003 Oct; 170(4 Pt 1):1383-7. PubMed ID: 14501774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of P-glycoprotein, multidrug resistance-associated protein 1, and lung resistance-related protein in human soft tissue sarcomas before and after hyperthermic isolated limb perfusion with tumor necrosis factor-alpha and melphalan.
    Komdeur R; Plaat BE; Hoekstra HJ; Molenaar WM; Hollema H; van den Berg E; Mastik MF; van der Graaf WT
    Cancer; 2001 May; 91(10):1940-8. PubMed ID: 11346877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug resistance: retrospect and prospects in anti-cancer drug treatment.
    Pérez-Tomás R
    Curr Med Chem; 2006; 13(16):1859-76. PubMed ID: 16842198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of multidrug resistance 1 (MDR1), multidrug resistance-related protein 1 (MRP1), lung resistance protein (LRP), and breast cancer resistance protein (BCRP) genes and clinical outcome in childhood acute lymphoblastic leukemia.
    Kourti M; Vavatsi N; Gombakis N; Sidi V; Tzimagiorgis G; Papageorgiou T; Koliouskas D; Athanassiadou F
    Int J Hematol; 2007 Aug; 86(2):166-73. PubMed ID: 17875533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of multidrug resistance proteins, P-gp, MRP1 and LRP, in soft tissue sarcomas analysed according to their histological type and grade.
    Komdeur R; Plaat BE; van der Graaf WT; Hoekstra HJ; Hollema H; van den Berg E; Zwart N; Scheper RJ; Molenaar WM
    Eur J Cancer; 2003 May; 39(7):909-16. PubMed ID: 12706359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of ABC-cassette transporters (MDR1, MRP1, BCRP) in the development of primary and acquired multiple drug resistance in patients with early and metastatic breast cancer.
    Kovalev AA; Tsvetaeva DA; Grudinskaja TV
    Exp Oncol; 2013 Dec; 35(4):287-90. PubMed ID: 24382439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidrug resistance proteins in rhabdomyosarcomas: comparison between children and adults.
    Komdeur R; Klunder J; van der Graaf WT; van den Berg E; de Bont ES; Hoekstra HJ; Molenaar WM
    Cancer; 2003 Apr; 97(8):1999-2005. PubMed ID: 12673730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABCB1 and ABCG2 proteins, their functional activity and gene expression in concert with drug sensitivity of leukemia cells.
    Svirnovski AI; Shman TV; Serhiyenka TF; Savitski VP; Smolnikova VV; Fedasenka UU
    Hematology; 2009 Aug; 14(4):204-12. PubMed ID: 19635183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of MDR1, LRP, BCRP and Bcl-2 genes at diagnosis of childhood all: comparison with MRD status after induction therapy.
    Fedasenka UU; Shman TV; Savitski VP; Belevcev MV
    Exp Oncol; 2008 Sep; 30(3):248-52. PubMed ID: 18806751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidrug resistance genes in infant acute lymphoblastic leukemia: Ara-C is not a substrate for the breast cancer resistance protein.
    Stam RW; van den Heuvel-Eibrink MM; den Boer ML; Ebus ME; Janka-Schaub GE; Allen JD; Pieters R
    Leukemia; 2004 Jan; 18(1):78-83. PubMed ID: 14574327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of efflux transporters in human ocular tissues.
    Chen P; Chen H; Zang X; Chen M; Jiang H; Han S; Wu X
    Drug Metab Dispos; 2013 Nov; 41(11):1934-48. PubMed ID: 23979916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD34-related coexpression of MDR1 and BCRP indicates a clinically resistant phenotype in patients with acute myeloid leukemia (AML) of older age.
    van den Heuvel-Eibrink MM; van der Holt B; Burnett AK; Knauf WU; Fey MF; Verhoef GE; Vellenga E; Ossenkoppele GJ; Löwenberg B; Sonneveld P
    Ann Hematol; 2007 May; 86(5):329-37. PubMed ID: 17340137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of expression of MRP1, BCRP, LRP and ERCC1 with outcome of patients with locally advanced non-small cell lung cancer who received neoadjuvant chemotherapy.
    Li J; Li ZN; Yu LC; Bao QL; Wu JR; Shi SB; Li XQ
    Lung Cancer; 2010 Jul; 69(1):116-22. PubMed ID: 19875192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of drug transporters and drug accumulation in the temporal acquisition of drug resistance.
    Hembruff SL; Laberge ML; Villeneuve DJ; Guo B; Veitch Z; Cecchetto M; Parissenti AM
    BMC Cancer; 2008 Nov; 8():318. PubMed ID: 18980695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular colocalization of P-glycoprotein, multidrug-resistance associated protein 1, breast cancer resistance protein and major vault protein in human epileptogenic pathologies.
    Sisodiya SM; Martinian L; Scheffer GL; van der Valk P; Scheper RJ; Harding BN; Thom M
    Neuropathol Appl Neurobiol; 2006 Feb; 32(1):51-63. PubMed ID: 16409553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistance.
    Shi Z; Peng XX; Kim IW; Shukla S; Si QS; Robey RW; Bates SE; Shen T; Ashby CR; Fu LW; Ambudkar SV; Chen ZS
    Cancer Res; 2007 Nov; 67(22):11012-20. PubMed ID: 18006847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.